A randomized clinical trial examined patient quality of life in Parkinson disease (PD) when adding different adjuvant therapies to levodopa to help control dyskinesia and a flaring of symptoms during OFF periods to see if one drug class had any benefit over another.
Low functional status based on Duke Activity Status Instrument score was associated with higher cardiometabolic risk among individuals 45 years and older living with HIV, this new multinational cohort study found.
During a panel at the Community Oncology Alliance’s Community Oncology Conference, speakers discuss practice-level efforts to reduce cancer care disparities.
Recent research presented at the 2022 American Academy of Allergy, Asthma & Immunology Annual Meeting examined different aspects of the use of biologics for severe asthma.
As a result of being less likely than men to receive lifesaving treatment when experiencing cardiogenic shock, women were significantly less likely to survive in the short and long term.
Lalan Wilfong, MD, vice president of Payer Relations & Practice Transformation at The US Oncology Network, speaks on how use of health economics and outcomes research has benefitted patient care in the community oncology setting and where it can be further leveraged in the pursuit of value-based care.
Incident end-stage kidney disease cases more than doubled among Asian individuals, and prevalent cases more than tripled for Asian, Native Hawaiian or other Pacific Islander, and Hispanic individuals.
Eosinophilic esophagitis (EoE) is triggered by food and in this interview, Colette Romero, whose son has the disease, discusses the financial implications for families, including equity considerations.
This review sought to give more information about the types of treadmill training that might be beneficial for patients with Parkinson disease and other neurological disorders engaged in physical rehabilitation programs.
Ben Jones, vice president, Government Relations & Public Policy, The US Oncology Network, addresses potential reform at the federal and state level that could accelerate the pursuit of value-based care in the community oncology setting.
OneOncology, a national platform for independent oncology practices, announced 2 partnerships this week.
Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute, speaks on takeaways from his discussions on site of care and pharmacy benefit managers (PBMs) at the 2022 Community Oncology Conference.
This new investigation evaluated outcomes among 6 youths with type 1 diabetes, who had public insurance coverage and received continuous glucose monitoring assistance through the CGM Time in Range Program.
Medicare advantage beneficiaries who received care from providers in 2-sided risk payment models had lower rates of acute care use, according to new study findings.
The study called for increased education, productive health care professional dialogue, and shared decision-making in the management of patients with psoriasis and psoriatic arthritis.
The phase 3 trial of valoctocogene roxaparvovec for severe hemophilia A showed it reduced bleeding events as well as the use of factor VIII concentrates.
FDA issued a complete response letter (CRL) to AstraZeneca seeking additional clinical data for benralizumab, sold as Fasenra, in the treatment of patients with inadequately controlled chronic rhinosinusitis with nasal polyps.
This new meta-analysis from World Health Organization and University of Cape Town investigators analyzed adverse posthospitalization discharge outcomes and related risk factors among persons living with HIV.
On this episode of Managed Care Cast, Anna Forsythe, PharmD, MSc, MBA, vice president of value and access at Cytel, explains the monetary and humanistic costs of conversion therapy among LGBTQ+ populations in the United States.
Idaho legislature passed Texas-inspired abortion law banning the procedure after 6 weeks of pregnancy; patients who were bedridden with severe cases of COVID-19 had increased risks of anxiety and depression more than a year later; number of deaths by suicide in Japanese women rose for second straight year.
Longer-term findings of the Measure Up 1 and 2 studies showed the JAK inhibitor upadacitinib to be safe and effective after 52 weeks in the treatment of adults and adolescents with moderate to severe atopic dermatitis.
Researchers outlined trends in treatment and management for patients presenting to the emergency department with headaches.
Cardiac troponin I (cTnI) and N-terminal pro-brain-type natriuretic peptide (NT-proBNP) were associated with incident cardiovascular events in patients with psoriatic disease.
Screening for colorectal cancer is an urgent priority for Americans aged 45 and older; low COVID-19 vaccine uptake was observed among US children aged 5 to 11 years in the first weeks of eligibility; WHO warns of increased alcohol consumption risk due to the pandemic.
A majority of patients with ophthalmic video visits were satisfied, but there were some predictors that contributed to which patients were more satisfied, explained Darren Chen, MD student at Weill Cornell Graduate School of Medical Sciences.
